- Home
- ICAD vs CVM Comparison
ICAD vs CVM Comparison
Compare ICAD & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- CVM
- Stock Information
- Founded
- ICAD 1984
- CVM 1983
- Country
- ICAD United States
- CVM United States
- Employees
- ICAD N/A
- CVM N/A
- Industry
- ICAD Medical/Dental Instruments
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ICAD Health Care
- CVM Health Care
- Exchange
- ICAD Nasdaq
- CVM Nasdaq
- Market Cap
- ICAD 40.8M
- CVM 40.1M
- IPO Year
- ICAD 1986
- CVM 1987
- Fundamental
- Price
- ICAD $1.68
- CVM $0.62
- Analyst Decision
- ICAD
- CVM
- Analyst Count
- ICAD 0
- CVM 0
- Target Price
- ICAD N/A
- CVM N/A
- AVG Volume (30 Days)
- ICAD 337.8K
- CVM 469.2K
- Earning Date
- ICAD 11-13-2024
- CVM 02-12-2025
- Dividend Yield
- ICAD N/A
- CVM N/A
- EPS Growth
- ICAD N/A
- CVM N/A
- EPS
- ICAD N/A
- CVM N/A
- Revenue
- ICAD $18,940,000.00
- CVM N/A
- Revenue This Year
- ICAD $10.15
- CVM N/A
- Revenue Next Year
- ICAD $3.75
- CVM $3,412.81
- P/E Ratio
- ICAD N/A
- CVM N/A
- Revenue Growth
- ICAD 10.03
- CVM N/A
- 52 Week Low
- ICAD $1.18
- CVM $0.49
- 52 Week High
- ICAD $2.65
- CVM $3.23
- Technical
- Relative Strength Index (RSI)
- ICAD 43.66
- CVM 45.83
- Support Level
- ICAD $1.65
- CVM $0.60
- Resistance Level
- ICAD $2.13
- CVM $0.78
- Average True Range (ATR)
- ICAD 0.17
- CVM 0.09
- MACD
- ICAD -0.00
- CVM 0.02
- Stochastic Oscillator
- ICAD 6.12
- CVM 45.66
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.